Heart failure with reduced ejection fraction: a review
10.1001/jama.2020.10262 · 2020
Risk profiles in heart failure: baseline, residual, worsening, and advanced heart failure risk
10.1161/circheartfailure.120.007132 · 2020
Honoring 50 years of clinical heart transplantation in circulation: in-depth state-of-the-art review
10.1161/circulationaha.117.029753 · 2018
Finding a solution to the organ shortage
10.1503/cmaj.151260 · 2016
Disparity between solid-organ supply and demand
10.1056/nejme038117 · 2003
Utilizing expanded donor selection criteria for heart transplantation: a single center experience
10.1016/j.healun.2017.01.098 · 2017
National decline in donor heart utilization with regional variability: 1995-2010
10.1111/ajt.13055 · 2015
National trends in heart donor usage rates: are we efficiently transplanting more hearts?
10.1161/jaha.120.019655 · 2021
Unresolved referenced work
2009
Donation after circulatory death: extending the boundaries of this new frontier
10.1016/j.healun.2021.07.029 · 2021
Human heart transplantation from donation after circulatory-determined death donors using normothermic regional perfusion and cold storage
10.1016/j.healun.2018.03.017 · 2018
Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial
10.1016/s0140-6736(15)60261-6 · 2015
Machine perfusion in solid organ transplantation: where is the benefit?
10.1007/s00423-014-1161-2 · 2014
Experience with the first 50 ex vivo lung perfusions in clinical transplantation
10.1016/j.jtcvs.2012.08.009 · 2012
Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation
10.1016/j.healun.2014.09.044 · 2015
Organ donation in adults: a critical care perspective
10.1007/s00134-015-4191-5 · 2016
Evaluation of the organ care system in heart transplantation with an adverse donor/recipient profile
10.1016/j.athoracsur.2014.06.098 · 2014
Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series
10.1016/s0140-6736(15)60038-1 · 2015
Myocardial functional decline during prolonged ex situ heart perfusion
10.1016/j.athoracsur.2019.01.076 · 2019
Comparing donor heart assessment strategies during ex situ heart perfusion to better estimate posttransplant cardiac function
10.1097/tp.0000000000003374 · 2020
A cardioprotective preservation strategy employing ex vivo heart perfusion facilitates successful transplant of donor hearts after cardiocirculatory death
10.1016/j.healun.2013.04.016 · 2013
The implementation of physiological afterload during ex situ heart perfusion augments prediction of posttransplant function
10.1152/ajpheart.00427.2019 · 2020
The implementation of an adjustable afterload module for ex situ heart perfusion
10.1007/s13239-019-00447-w · 2020
A new multi-mode perfusion system for ex vivo heart perfusion study
10.1007/s10916-017-0882-5 · 2017
Inhibiting the Pkm2/b-catenin axis drives in vivo replication of adult cardiomyocytes following experimental MI
10.1038/s41418-020-00669-9 · 2021
Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine
2006
Transplantation of hearts donated after circulatory death
10.3389/fcvm.2018.00008 · 2018
Dynamic metabolic changes during prolonged ex situ heart perfusion are associated with myocardial functional decline
10.3389/fimmu.2022.859506 · 2022
Twenty-four-hour normothermic perfusion of isolated ex vivo hearts using plasma exchange
10.1016/j.jtcvs.2020.11.158 · 2022
Invasive left ventricle pressure-volume analysis: overview and practical clinical implications
10.1093/eurheartj/ehz552 · 2020
Left ventricular contractility predicts how the end-diastolic pressure-volume relation shifts during pacing-induced ischemia in dogs
10.1161/01.cir.91.9.2423 · 1995
Development of left ventricular hypertrophy in treated hypertensive outpatients: the Campania Salute Network
10.1161/hypertensionaha.116.08158 · 2017
Unresolved referenced work
2023
Physiology of cardiac performance
1993
Cardiac allograft vasculopathy: a review
2005
Cardiac allograft vasculopathy: a review
10.1161/01.cir.96.6.2069 · 1997
Role of catalase in oxidative stress- and age-associated degenerative diseases
10.1155/2019/9613090 · 2019
Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the “L-arginine paradox” and acts as a novel cardiovascular risk factor
10.1093/jn/134.10.2842s · 2004
Nitric oxide as a cellular antioxidant: a little goes a long way
10.1016/j.freeradbiomed.2005.08.047 · 2006
p53, oxidative stress, and aging
10.1089/ars.2010.3644 · 2011
